CellaVision AB (publ) (CLVSF)

Market Cap	399.56M
Revenue (ttm)	65.35M
Net Income (ttm)	12.72M
Shares Out	n/a
EPS (ttm)	0.53
PE Ratio	31.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	157
Average Volume	535
Open	19.28
Previous Close	19.91
Day's Range	19.28 - 19.28
52-Week Range	19.28 - 25.91
Beta	1.23
RSI	45.66
Earnings Date	Apr 29, 2025

About CellaVision AB

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers, instruments; and hardware products include in vitro diagnostics IVD for laboratories; as well as its portfolio includes smear makers, stainers, stains, and staining protocols; DIFF-Line is a hematology lab that handles a smaller amount daily blood samples and consists three instruments for smearing, staining, and analyzing ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 219
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLVSF

Financial Performance

In 2024, CellaVision AB's revenue was 723.22 million, an increase of 6.78% compared to the previous year's 677.29 million. Earnings were 140.72 million, an increase of 7.99%.

Financial numbers in SEK